RFP/GFP tumor hybrids were clearly identified in tumors derived from H2B-RFP-expressing murine melanoma B16F10 cells that were intradermally injected in actin-GFP mice [17], indicating that cells have fused in vivo. The gene discussed is H2BC21; the disease is neoplasm.